Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Daklinza

 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

daclatasvirdaclatasvir dihydrochloride
daclatasvir 30 MG Oral Tablet [Daklinza]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
China FDA Approves Country’s First All-Oral Regimen for Chronic Hepatitis C, Daklinza® (daclatasvir) in Combination with Sunvepra® (asunaprevir)
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) announced today that the China Food and Drug… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE